Bristol Myers Squibb (U.S.), Qilu Pharmaceutical Ltd (China), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly And Company (U.S.), Engeneic Ltd , F. Hoffmann-la Roche AG (Switzerland), Merck & Co. Inc. (U.S.), Novartis International AG (Switzerland), Pfizer Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of oral cancer, globally.
Oral cancer is the cancer that occur in the mouth, and develop in any part that make up the mouth. This cancer develops uncontrolled cancerous cells in any part of your mouth such as lips, gums, tongue, roof of the mouth, etc. According to the Cancer Research UK, in 2014, 1 in 75 men and 1 in 150 women will be diagnosed with oral cancer during their lifetime. Report suggest that chances of occurring oral cancer is more common in White males than in Black males.
Global Oral Cancer Treatment Market – Overview
The global Oral Cancer Treatment Market is showing the steady growth; mainly owing to increase in patient population. According to a report published by the American Society of Clinical Oncology, in 2016, it is estimated that around 49,670 adults (35,720 men and 13,950 women) in the United States will be diagnosed with oral and oropharyngeal cancer this year. Further, as per the Oral Cancer Foundation, in 2015, around 12,920 adults were estimated to have mouth cancer. These rising number of oral cancer creates an opportunity for the players to introduce innovative treatment options.
Companies are continuously inventing in new treatment to capture the global market. Thus, players are investing more in research and development activities. In this regards, Bristol Myers Squibb, 2016, announced that they got the approval for Opdivo injection, which helps in the treatment of infected patients. These companies are investing more in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.
In 2017, Merck & Co. Inc. announced the development on phase three study of KEYTRUDA, company update that, in august 2016, he U.S. Food and Drug Administration (FDA) approved KEYTRUDA for the treatment of patients of oral cancer. This invention help Merck & Co. Inc. to meet the goal of translate breakthrough science into innovative oncology medicines to help people with cancer worldwide. Increasing in the consumption of tobacco, alcohol, and sun exposure leads the incidence of oral mouth cancer.
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1820 .
Global Oral Cancer Treatment Market – Regional Analysis
According to the National Cancer Registry Ireland, in 2015, Head & Neck Cancer which including oral cancer too, increasing in both men and women in Ireland, and it found that it is more common in men than women. Report suggests that around 16% of cases were below 50 years who were diagnosed with these cancer. The market of oral cancer is much higher in the Americas region attribute to high rate of tobacco consumption. According to report published by American Academy of Otolaryngology, in 2016, In the United States, up to 200,000 people die each year from smoking-related illnesses that leads to incidence of oral cancer in this region. The government have more focus towards research and development for introducing the best treatment for their population.
Europe is also consider huge market for oral cancer treatment players, owing to present of huge population affected with disease. According to Cancer Research U.K, in 2014, new cases of oral cancer were 11, 449 and around 2,386 people died due to oral cancer. Government are more focusing to educate their public in order to minimize the patient’s population by educating them about the side effect of tobacco, alcohol etc.
Asia Pacific region are considering the growing market, owing to presence of huge population suffering with oral cancer. Whereas, countries like India and China are considered fastest growing regions due to the high rate of tobacco and alcohol consumption which leads the incidence of oral cancer, additionally they are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their citizen. Whereas the Middle East and Africa have low market due to lack of investment, Moreover, developing countries are still focusing on new drugs for the treatment of oral cancer, this gap between the developed and developing countries will present significant growth opportunity for the oral cancer treatment market players in the coming years.
Get Discount @ https://www.marketresearchfuture.com/check-discount/1820 .
We are thankful for the support and assistance from Global Oral cancer Treatment Market Research Report – Forecast till 2022 chain related technical experts and marketing experts during Research Team survey and interviews.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312